Patients as Candidates for Drug Therapy According to the SCORE Guidelines Recommendations, With Risk Estimated by the Original Framingham and REGICOR Risk Functions
| Recommended Therapy | Total (n=447) | Men (n=201) | Women (n=246) |
|---|---|---|---|
| Lipid-lowering therapy | |||
| Original Framingham, n (%) | 64 (14.3) | 57 (28.3) | 7 (2.8) |
| REGICOR Framingham, n (%) | 30 (6.7) | 26 (12.9) | 4 (1.6) |
| P value | <.001 | <.001 | .360 |
| Antihypertensive therapy | |||
| Original Framingham, n (%) | 56 (12.5) | 41 (20.4) | 15 (6.1) |
| REGICOR Framingham, n (%) | 35 (7.8) | 23 (11.4) | 12 (4.9) |
| P value | <.05 | <.05 | .55 |